WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H563738
CAS#: 2040055-81-8
Description: PF-04363467 HCl is a selective dopamine D3/D2 receptor antagonist.
Hodoodo Cat#: H563738
Name: PF-04363467 HCl
CAS#: 2040055-81-8
Chemical Formula: C22H31ClN2O3S
Exact Mass: 438.17
Molecular Weight: 439.010
Elemental Analysis: C, 60.19; H, 7.12; Cl, 8.07; N, 6.38; O, 10.93; S, 7.30
Synonym: PF-04363467 hydrochloride; PF-04363467 HCl;
IUPAC/Chemical Name: (S)-N-[4-(4-Ethyl-2-morpholinyl)-2-methylphenyl]-4-(1-methylethyl)benzenesulfonamide hydrochloride
InChi Key: LDMGPGYFWNPBTL-VZYDHVRKSA-N
InChi Code: InChI=1S/C22H30N2O3S.ClH/c1-5-24-12-13-27-22(15-24)19-8-11-21(17(4)14-19)23-28(25,26)20-9-6-18(7-10-20)16(2)3;/h6-11,14,16,22-23H,5,12-13,15H2,1-4H3;1H/t22-;/m1./s1
SMILES Code: O=S(C1=CC=C(C(C)C)C=C1)(NC2=CC=C([C@H]3CN(CC)CCO3)C=C2C)=O.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 439.01 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |